| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 12.089 | 19.039 | 42.665 | 60.180 | 63.174 | 97.103 | 110.877 |
| Total Income - EUR | - | - | - | 12.089 | 19.040 | 42.665 | 60.181 | 65.138 | 97.104 | 110.878 |
| Total Expenses - EUR | - | - | - | 6.644 | 16.764 | 36.633 | 46.392 | 50.455 | 66.770 | 95.694 |
| Gross Profit/Loss - EUR | - | - | - | 5.444 | 2.276 | 6.032 | 13.789 | 14.683 | 30.334 | 15.184 |
| Net Profit/Loss - EUR | - | - | - | 5.081 | 1.704 | 4.752 | 11.983 | 12.787 | 25.480 | 10.824 |
| Employees | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 2 |
Check the financial reports for the company - Taloşfam-Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 0 | 0 | 5.454 | 3.521 | 1.640 | 2.664 |
| Current Assets | - | - | - | 5.267 | 6.891 | 11.957 | 18.125 | 32.999 | 42.297 | 26.827 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 1.178 | 1.568 | 4.274 | 4.404 | 4.876 | 18.602 | 21.455 |
| Cash | - | - | - | 4.089 | 5.323 | 7.683 | 381 | 28.123 | 23.695 | 5.371 |
| Shareholders Funds | - | - | - | 5.124 | 6.729 | 11.354 | 23.085 | 15.666 | 41.099 | 11.487 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 142 | 161 | 603 | 494 | 20.853 | 2.837 | 18.003 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Taloşfam-Med S.r.l.